| Ellie Mental Health | |
|
238 Hoover Blvd Ste 30 Holland MI 49423-3782 | |
| (616) 312-2989 | |
| Not Available |
| Full Name | Ellie Mental Health |
|---|---|
| Speciality | Social Worker |
| Location | 238 Hoover Blvd Ste 30, Holland, Michigan |
| Authorized Official Name and Position | Rebecca Stevens (CLINIC DIRECTOR) |
| Authorized Official Contact | 6164272966 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ellie Mental Health 238 Hoover Blvd Ste 30 Holland MI 49423-3782 Ph: (616) 312-2989 | Ellie Mental Health 238 Hoover Blvd Ste 30 Holland MI 49423-3782 Ph: (616) 312-2989 |
| NPI Number | 1093420960 |
|---|---|
| Provider Enumeration Date | 01/16/2023 |
| Last Update Date | 03/22/2023 |
| Certification Date | 03/22/2023 |
| Medicare PECOS PAC ID | 4082088588 |
|---|---|
| Medicare Enrollment ID | O20230324000348 |
News Archive
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093420960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Gregory R Lott |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1548226202 PECOS PAC ID: 1355312141 Enrollment ID: I20040804001306 |
News Archive
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
› Verified 2 days ago
| Provider Name | Rebecca J Stevens |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1427295773 PECOS PAC ID: 0547310146 Enrollment ID: I20090602000273 |
News Archive
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
› Verified 2 days ago
| Provider Name | Jennifer Fopma |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1780376822 PECOS PAC ID: 3577923119 Enrollment ID: I20230714001285 |
News Archive
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
› Verified 2 days ago
| Provider Name | Zoe C Steiner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1982165718 PECOS PAC ID: 2860846862 Enrollment ID: I20230925003188 |
News Archive
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
› Verified 2 days ago
News Archive
Dynavax Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold for the HEPLISAVTM Investigational New Drug (IND) application in individuals with chronic kidney disease.
Depomed, Inc. today announced that a report of Phase 3 data published online this month, ahead of the print edition, in the Clinical Journal of Pain showed that once-daily Gralise (gabapentin) tablets (1,800 mg) formulation significantly reduces intensity of pain in patients with postherpetic neuralgia (PHN).
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
The Republican governor pushed the state legislature to expand Medicaid coverage to most poor people in the state.
Five research projects with exceptional promise to deliver new life-changing and health-altering therapies have received the inaugural Blavatnik Therapeutics Challenge Awards (BTCA) at Harvard Medical School.
› Verified 2 days ago
Counseling & Consultation Resources Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 720 E 8th St, Suite 2, Holland, MI 49423 Phone: 616-355-0549 Fax: 616-355-0480 | |
Comprehensive Psyiatric Services Of Western Mi Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12978 James Street, Ste 10, Holland, MI 49424 Phone: 616-399-7005 Fax: 616-399-7150 | |
Benjamin's Hope Life Enrichment Program Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15468 Riley St, Holland, MI 49424 Phone: 616-399-6293 | |
Center For Family Development Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 347 Hoover Blvd, Suite A, Holland, MI 49423 Phone: 616-392-7695 Fax: 616-392-6955 | |
Holland Community Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3235 Wellness Dr, Holland, MI 49424 Phone: 616-392-5141 | |
Daniel G. Rooks, Psy.d., P.c. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3124 N Wellness Dr, Suite 30, Holland, MI 49424 Phone: 616-786-3350 Fax: 616-786-3375 | |
Ck Psychological Associates, P.c. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 246 S River Ave, Suite 105, Holland, MI 49423 Phone: 616-494-0808 Fax: 616-494-0011 |